145 related articles for article (PubMed ID: 9380952)
1. The proteoglycan metabolism, morphology and viability of articular cartilage treated with a synthetic matrix metalloproteinase inhibitor.
Steinmeyer J; Daufeldt S; Kalbhen DA
Res Exp Med (Berl); 1997; 197(2):63-79. PubMed ID: 9380952
[TBL] [Abstract][Full Text] [Related]
2. Effects of the hydroxamic acid derivate Ro 31-4724 on the metabolism and morphology of interleukin-1-treated cartilage explants.
Steinmeyer J; Daufeldt S; Kalbhen DA
Pharmacology; 1997 Aug; 55(2):95-108. PubMed ID: 9323309
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological influence of antirheumatic drugs on proteoglycans from interleukin-1 treated articular cartilage.
Steinmeyer J; Daufeldt S
Biochem Pharmacol; 1997 Jun; 53(11):1627-35. PubMed ID: 9264315
[TBL] [Abstract][Full Text] [Related]
4. Effect of Betula platyphylla var. japonica on proteoglycan release, type II collagen degradation, and matrix metalloproteinase expression in rabbit articular cartilage explants.
Cho YJ; Huh JE; Kim DY; Kim NJ; Lee JD; Baek YH; Cho EM; Yang HR; Choi DY; Park DS
Biol Pharm Bull; 2006 Jul; 29(7):1408-13. PubMed ID: 16819179
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological effect of tetracyclines on proteoglycanases from interleukin-1-treated articular cartilage.
Steinmeyer J; Daufeldt S; Taiwo YO
Biochem Pharmacol; 1998 Jan; 55(1):93-100. PubMed ID: 9413935
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation.
Buttle DJ; Handley CJ; Ilic MZ; Saklatvala J; Murata M; Barrett AJ
Arthritis Rheum; 1993 Dec; 36(12):1709-17. PubMed ID: 8250991
[TBL] [Abstract][Full Text] [Related]
7. The effect of naproxen and interleukin-1 on proteoglycan catabolism and on neutral metalloproteinase activity in normal articular cartilage in vitro.
Glazer PA; Rosenwasser MP; Ratcliffe A
J Clin Pharmacol; 1993 Feb; 33(2):109-14. PubMed ID: 8440758
[TBL] [Abstract][Full Text] [Related]
8. In vivo effects of naproxen on composition, proteoglycan metabolism, and matrix metalloproteinase activities in canine articular cartilage.
Ratcliffe A; Azzo W; Saed-Nejad F; Lane N; Rosenwasser MP; Mow VC
J Orthop Res; 1993 Mar; 11(2):163-71. PubMed ID: 8483029
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase inhibitor CGS 27023A protects COMP and proteoglycan in the bovine articular cartilage but not the release of their fragments from cartilage after prolonged stimulation in vitro with IL-1 alpha.
Ganu V; Melton R; Wang W; Roberts D
Ann N Y Acad Sci; 1999 Jun; 878():607-11. PubMed ID: 10415786
[No Abstract] [Full Text] [Related]
10. Effect of polysulfated glycosaminoglycan on DNA content and proteoglycan metabolism in normal and osteoarthritic canine articular cartilage explants.
Sevalla K; Todhunter RJ; Vernier-Singer M; Budsberg SC
Vet Surg; 2000; 29(5):407-14. PubMed ID: 10999454
[TBL] [Abstract][Full Text] [Related]
11. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures.
Kozaci LD; Buttle DJ; Hollander AP
Arthritis Rheum; 1997 Jan; 40(1):164-74. PubMed ID: 9008612
[TBL] [Abstract][Full Text] [Related]
12. Effects of stromelysin activity on proteoglycan degradation of canine articular cartilage explants.
Todhunter RJ; Yeh LA; Sheldon A; Grisanzio L; Walker SL; Burton-Wurster N; Lust G
Am J Vet Res; 1995 Sep; 56(9):1241-7. PubMed ID: 7486406
[TBL] [Abstract][Full Text] [Related]
13. The effects of methylprednisolone on normal and monocyte-conditioned medium-treated articular cartilage from dogs and horses.
Murphy DJ; Todhunter RJ; Fubini SL; Vernier-Singer M; Straubinger RK; Lust G
Vet Surg; 2000; 29(6):546-57. PubMed ID: 11098788
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage.
Little CB; Hughes CE; Curtis CL; Jones SA; Caterson B; Flannery CR
Arthritis Rheum; 2002 Jan; 46(1):124-9. PubMed ID: 11817583
[TBL] [Abstract][Full Text] [Related]
15. A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro.
Andrews HJ; Plumpton TA; Harper GP; Cawston TE
Agents Actions; 1992 Sep; 37(1-2):147-54. PubMed ID: 1456176
[TBL] [Abstract][Full Text] [Related]
16. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
[TBL] [Abstract][Full Text] [Related]
17. IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage.
Flannery CR; Little CB; Hughes CE; Curtis CL; Caterson B; Jones SA
Matrix Biol; 2000 Nov; 19(6):549-53. PubMed ID: 11068209
[TBL] [Abstract][Full Text] [Related]
18. Passive loss of proteoglycan from articular cartilage explants.
Bolis S; Handley CJ; Comper WD
Biochim Biophys Acta; 1989 Dec; 993(2-3):157-67. PubMed ID: 2512986
[TBL] [Abstract][Full Text] [Related]
19. Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants.
Chan PS; Caron JP; Orth MW
Am J Vet Res; 2005 Nov; 66(11):1870-6. PubMed ID: 16334942
[TBL] [Abstract][Full Text] [Related]
20. Effect of dimethylsulfoxide on articular cartilage proteoglycan synthesis and degradation, chondrocyte viability, and matrix water content.
Matthews GL; Engler SJ; Morris EA
Vet Surg; 1998; 27(5):438-44. PubMed ID: 9749514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
